Abstract
Basal cell carcinoma (BCC) is the most prevalent human neoplasm, with constantly increasing annual incidence. Despite its slow growth, BCC is locally invasive and, if left untreated, can cause severe complications, including metastasis and death. The renin-angiotensin system (RAS) plays a key role in electrolyte balance, atrial pressure, tissue development, homeostasis, and inflammation, but also in cancer development. After binding to its type 1 receptor (AT1R), angiotensin II (ANGII), the system's principal hormonal effector, regulates cancer pathways spanning from the formation of the initial cancer cell to the construction and nutrition of the tumor microenvironment, angiogenesis, proliferation, and metastasis. Although the role of RAS in the development of skin pathologies has not been widely researched, RAS-targeting antihypertensive medications have been shown to have a chemoprotective effect against BCC. Based on those findings, our group conducted a series of genetic association studies to investigate the association between common functional variations in key genes related to ANGII production (AGT, ACE, ACE2, AT1R, AT2R, and CMA1) and the risk of BCC occurrence. This review provides a summary of the current understanding of the ANGII involvement in BCC development. The reliable and easily assessed pool of genetic biomarkers may be used for predictive testing and prevention purposes in high-risk individuals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ager EI, Neo J, Christophi C (2008) The renin-angiotensin system and malignancy. Carcinogenesis 29:1675–1684. https://doi.org/10.1093/carcin/bgn171
Aleksandra Z, Zbigniew J, Waldemar M et al (2016) The AGT gene M235T polymorphism and response of power-related variables to aerobic training. J Sports Sci Med 15:616–624
Almutlaq M, Alamro AA, Alamri HS, Alghamdi AA, Barhoumi T (2021) The effect of local renin angiotensin system in the common types of cancer. Front Endocrinol 12:736361. https://doi.org/10.3389/fendo.2021.736361
Amaya K, Ohta T, Kitagawa H et al (2004) Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells. Int J Oncol 25:849–856. https://doi.org/10.3892/ijo.25.4.849
Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30:921–925. https://doi.org/10.1016/j.cub.2020.06.081
Anguiano L, Riera M, Pascual J, Soler MJ (2017) Circulating ACE2 in cardiovascular and kidney diseases. Curr Med Chem 24:3231–3241. https://doi.org/10.2174/0929867324666170414162841
Asselta R, Paraboschi EM, Mantovani A, Duga S (2020) ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging 12:10087–10098. https://doi.org/10.18632/aging.103415
Balmforth AJ (2010) Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 11:79–85. https://doi.org/10.1177/1470320309347782
Bernstein KE, Ong FS, Blackwell WL et al (2012) A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev 65:1–46. https://doi.org/10.1124/pr.112.006809
Bernstein KE, Khan Z, Giani JF, Cao DY, Bernstein EA, Shen XZ (2018) Angiotensin-converting enzyme in innate and adaptive immunity. Nat Rev Nephrol 14:325–336. https://doi.org/10.1038/nrneph.2018.15
Bertero E, Ameri P, Maack C (2019) Bidirectional relationship between cancer and heart failure: old and new issues in cardio-oncology. Card Fail Rev 5:106–111. https://doi.org/10.15420/2Fcfr.2019.1.2
Cameron MC, Lee E, Hibler BP et al (2019) Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 80:303–317. https://doi.org/10.1016/j.jaad.2018.03.060
Caughey GH, Zerweck EH, Vanderslice P (1991) Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem 266:12956–12963. https://doi.org/10.1016/S0021-9258(18)98788-0
Caughey GH, Schaumberg TH, Zerweck EH, Butterfield JH, Hanson RD, Silverman GA, Ley TJ (1993) The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 15:614–620. https://doi.org/10.1006/geno.1993.1115
Chappell MC (2016) Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol 310:137–152. https://doi.org/10.1152/ajpheart.00618.2015
Charalampidou S, Gintoni I, Avgoustidis D, Papakosta V, Vlachakis D, Vassiliou S, Yapijakis C (2022) Association between a high gene expression variant of chymase and increased risk for basal cell carcinoma. Anticancer Res 42:5547–5552. https://doi.org/10.21873/anticanres.16060
Cheng JL, Wang AL, Wan J (2012) Association between the M235T polymorphism of the AGT gene and cytokines in patients with hypertension. Exp Ther Med 3:509–512. https://doi.org/10.3892/etm.2011.433
Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA (2008) Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst 100:1223–1232. https://doi.org/10.1093/jnci/djn262
Chung FM, Yang YH, Chen CH, Lin CC, Shieh TY (2005) Angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers. Br J Cancer 93:602–606. https://doi.org/10.1038/sj.bjc.6602746
Clauser E, Gaillard I, Wei L, Corvol P (1989) Regulation of angiotensinogen gene. Am J Hypertens 2:403–410. https://doi.org/10.1093/ajh/2.5.403
Cole J, Ertoy D, Lin H et al (2000) Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 106:1391–1398. https://doi.org/10.1172/2FJCI10557
de Moura MM, dos Santos RA, Campagnole-Santos MJ, Todiras M, Bader M, Alenina N, Haibara AS (2010) Altered cardiovascular reflexes responses in conscious angiotensin-(1-7) receptor mas-knockout mice. Peptides 31:1934–1939. https://doi.org/10.1016/j.peptides.2010.06.030
de Paula GALAC, Palmeira VA, Ribeiro TFS, Costa LB, de Sá Rodrigues KE, Simões-E-Silva AC (2020) ACE2/angiotensin-(1-7)/mas receptor axis in human cancer: potential role for pediatric tumors. Curr Drug Targets 21:892–901. https://doi.org/10.2174/1389450121666200210124217
Dell’Italia LJ, Husain A (2002) Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr Opin Cardiol 17:374–379. https://doi.org/10.1097/00001573-200207000-00009
Deshayes F, Nahmias C (2005) Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 16:293–299. https://doi.org/10.1016/j.tem.2005.07.009
Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Harvima IT (2007) The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma. J Eur Acad Dermatol Venereol 21:908–915. https://doi.org/10.1111/j.1468-3083.2006.02100.x
Donoghue M, Hsieh F, Baronas E et al (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87:1–9. https://doi.org/10.1161/01.res.87.5.e1
Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 292:373–381. https://doi.org/10.1152/ajpregu.00292.2006
Emdin M, Fatini C, Mirizzi G et al (2015) Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? Clin Chim Acta 443:85–93. https://doi.org/10.1016/j.cca.2014.10.031
Fairhurst-Hunter Z, Walters RG, Zink A et al (2022) Investigation into the health effects of reduced chymase function using predicted loss-of-function mutations in CMA1. J Cardiovasc Transl Res 15:1474–1476. https://doi.org/10.1007/2Fs12265-022-10261-w
Feng LH, Sun HC, Zhu XD et al (2021) Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma. Ann Transl Med 9:207–222. https://doi.org/10.21037/2Fatm-20-5293
Fraga-Silva RA, Pinheiro SV, Gonçalves AC, Alenina N, Bader M, Santos RA (2008) The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. Mol Med 14:28–35. https://doi.org/10.2119/2007-00073.fraga-silva
Freitas-Silva M, Pereira D, Coelho C, Bicho M, Lopes C, Medeiros R (2004) Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 155:42–46. https://doi.org/10.1016/j.cancergencyto.2004.03.020
Gaillard I, Clauser E, Corvol P (1989) Structure of human angiotensinogen gene. DNA 8:87–99. https://doi.org/10.1089/dna.1.1989.8.87
Garcia-Garduño TC, Padilla-Gutierrez JR, Cambrón-Mora D, Valle Y (2021) RAAS: a convergent player in ischemic heart failure and cancer. Int J Mol Sci 22:7106–7124. https://doi.org/10.3390/ijms22137106
George AJ, Thomas WG, Hannan RD (2010) The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 10:745–759. https://doi.org/10.1038/nrc2945
Gimenez-Roqueplo AP, Célérier J, Lucarelli G, Corvol P, Jeunemaitre X (1998) Role of N-glycosylation in human angiotensinogen. J Biol Chem 273:21232–21238. https://doi.org/10.1074/jbc.273.33.21232
Gintoni I, Vassiliou S, Avgoustidis D et al (2021) Association between the ACE2 G8790A gene variation and risk for basal cell carcinoma. Anticancer Res 41:4021–4026. https://doi.org/10.21873/anticanres.15201
Gintoni I, Adamopoulou M, Yapijakis C (2021) The angiotensin-converting enzyme insertion/deletion polymorphism as a common risk factor for major pregnancy complications. In Vivo 35:95–103. https://doi.org/10.21873/2Finvivo.12236
Gintoni I, Adamopoulou M, Yapijakis C (2022) The impact of ACE and ACE2 gene polymorphisms in pulmonary diseases including COVID-19. In Vivo 36:13–29. https://doi.org/10.21873/invivo.12672
Görlach A, Kietzmann T (2007) Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol 435:421–446. https://doi.org/10.1016/s0076-6879(07)35022-2
Goto Y, Ando T, Nishio K, Ishida Y, Kawai S, Goto H, Hamajima N (2005) The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 6:464–467
Gupta N, Ruiz ES (2022) Current perspectives in the treatment of locally advanced basal cell carcinoma. Drug Des Devel Ther 16:183–190. https://doi.org/10.2147/dddt.s325852
Haiman CA, Henderson SO, Bretsky P, Kolonel LN, Henderson BE (2003) Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 63:6984–6987
Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631–637. https://doi.org/10.1002/path.1570
Hamming I, Cooper ME, Haagmans BL et al (2007) The emerging role of ACE2 in physiology and disease. J Pathol 212:1–11. https://doi.org/10.1002/path.2162
Herath CB, Warner FJ, Lubel JS et al (2007) Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 47:387–395. https://doi.org/10.1016/j.jhep.2007.03.008
Hollestein LM, de Vries E, Aarts MJ, Schroten C, Nijsten TE (2014) Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989. J Am Acad Dermatol 71:896–903. https://doi.org/10.1016/j.jaad.2014.07.003
Hossny EM, Amr NH, Elsayed SB, Nasr RA, Ibraheim EM (2008) Association of polymorphisms in the mast cell chymase gene promoter region (-1903 g/A) and (TG)n(GA)m repeat downstream of the gene with bronchial asthma in children. J Investig Allergol Clin Immunol 18:376–381
Hu J, Igarashi A, Kamata M, Nakagawa H (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276:47863–47868. https://doi.org/10.1074/jbc.m104068200
Huber MA, Azoitei N, Baumann B et al (2004) NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114:569–581. https://doi.org/10.1172/jci21358
Hubert C, Houot AM, Corvol P, Soubrier F (1991) Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 266:15377–15383. https://doi.org/10.1016/S0021-9258(18)98626-6
Hubert C, Savary K, Gasc JM, Corvol P (2006) The hematopoietic system: a new niche for the renin-angiotensin system. Nat Clin Pract Cardiovasc Med 3:80–85. https://doi.org/10.1038/ncpcardio0449
Ishikane S, Takahashi-Yanaga F (2018) The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis. Biochem Pharmacol 151:96–103. https://doi.org/10.1016/j.bcp.2018.03.008
Kim S, Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52:11–34
Komatsu T, Suzuki Y, Imai J et al (2002) Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2). DNA Seq 13:217–220. https://doi.org/10.1080/1042517021000021608
Koronellos N, Yapijakis C, Katoulis A et al (2021) Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma development. Arch Dermatol Res 313:373–380. https://doi.org/10.1007/s00403-020-02113-x
Kyrgidis A, Tzellos TG, Vahtsevanos K, Triaridis S (2010) New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors, and biomarkers. A systematic review of evidence regarding risk for tumor development, susceptibility for second primary and recurrence. J Surg Res 159:545–556. https://doi.org/10.1016/j.jss.2008.11.834
Lambert DW, Clarke NE, Turner AJ (2010) Not just angiotensinases: new roles for the angiotensin-converting enzymes. Cell Mol Life Sci 67:89–98. https://doi.org/10.1007/s00018-009-0152-x
Lear W, Dahlke E, Murray CA (2007) Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg 11:19–30. https://doi.org/10.2310/7750.2007.00011
Li YY (2012) Lack of association of ACE2 G8790A gene mutation with essential hypertension in the chinese population: a meta-analysis involving 5260 subjects. Front Physiol 3:364. https://doi.org/10.3389/fphys.2012.00364
Lin C, Yang HY, Wu CC et al (2014) Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension–a meta-regression analysis of 98 observational studies. PLoS One 9:87604–87620. https://doi.org/10.1371/2Fjournal.pone.0087604
Liu BC, Xia HL, Wu JN, Zhang XL, Liu DG, Gong YX (2007) Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction. Acta Pharmacol Sin 28:1810–1818. https://doi.org/10.1111/j.1745-7254.2007.00649.x
Liu B, Chen Y, St Clair DK (2008) ROS and p53: a versatile partnership. Free Radic Biol Med 44:1529–1535. https://doi.org/10.1016/j.freeradbiomed.2008.01.011
Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069–1080. https://doi.org/10.1111/j.1365-2133.2012.10830.x
Mackiewicz-Wysocka M, Bowszyc-Dmochowska M, Strzelecka-Węklar D, Dańczak-Pazdrowska A, Adamski Z (2013) Basal cell carcinoma—diagnosis. Contemp Oncol (Pozn) 17:337–342. https://doi.org/10.5114/wo.2013.35684
Marzuka AG, Book SE (2015) Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med 88:167–179
McDaniel B, Badri T, Steele RB (2022) Basal cell carcinoma. StatPearls Publishing, Treasure Island
Medeiros R, Vasconcelos A, Costa S et al (2004) Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202:330–335. https://doi.org/10.1002/path.1529
Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:82–97. https://doi.org/10.1152/ajpcell.00287.2006
Miller JA, Scholey JW (2004) The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens 13:101–106. https://doi.org/10.1097/00041552-200401000-00014
Moccia F, Gerbino A, Lionetti V et al (2020) COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Geroscience 42:1021–1049. https://doi.org/10.1007/s11357-020-00198-w
Molitor M, Rudi WS, Garlapati V et al (2021) Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1. Cardiovasc Res 117:162–177. https://doi.org/10.1093/cvr/cvaa042
Montagna E, Lopes OS (2017) Molecular basis of basal cell carcinoma. An Bras Dermatol 92:517–520. https://doi.org/10.1590/abd1806-4841.20176544
Moscarelli L, Zanazzi M, Mancini G et al (2010) Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients. Clin Nephrol 73:439–445. https://doi.org/10.5414/cnp73439
Mottl AK, Shoham DA, North KE (2008) Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 10:560–574. https://doi.org/10.1097/gim.0b013e3181809613
Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233–236. https://doi.org/10.1038/351233a0
Navar LG (2014) Physiology: hemodynamics, endothelial function, renin-angiotensin-aldosterone system, sympathetic nervous system. J Am Soc Hypertens 8:519–524. https://doi.org/10.1016/j.jash.2014.05.014
Pagé EL, Robitaille GA, Pouysségur J, Richard DE (2002) Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 277:48403–48409. https://doi.org/10.1074/jbc.m209114200
Pagliaro P, Penna C (2005) Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther 19:77–87. https://doi.org/10.1007/s10557-005-6900-8
Papaggelopoulos J, Angelopoulou A, Avgoustidis D, Koronellos N, Derka S, Vassiliou S, Yapijakis C (2019) Association of polymorphisms in the genes of angiotensinogen and angiotensin receptors with risk for basal cell carcinoma. Anticancer Res 39:5525–5530. https://doi.org/10.21873/anticanres.13745
Patel VB, Zhong JC, Fan D et al (2014) Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling. Hypertension 64:157–164. https://doi.org/10.1161/hypertensionaha.114.03388
Patel VB, Zhong JC, Grant MB, Oudit GY (2016) Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ Res 118:1313–1326. https://doi.org/10.1161/circresaha.116.307708
Patel S, Rauf A, Khan H, Abu-Izneid T (2017) Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother 94:317–325. https://doi.org/10.1016/j.biopha.2017.07.091
Pinheiro DS, Santos RS, Jardim PCBV, Silva EG, Reis AAS, Pedrino GR, Ulhoa CJ (2019) The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: a genetic association study in Brazilian patients. PLoS ONE 14:e0221248. https://doi.org/10.1371/journal.pone.0221248
Piqueras L, Kubes P, Alvarez A, O’Connor E, Issekutz AC, Esplugues JV, Sanz MJ (2000) Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation. Circulation 102:2118–2123. https://doi.org/10.1161/01.cir.102.17.2118
Rasha F, Ramalingam L, Gollahon L, Rahman RL, Rahman SM, Menikdiwela K, Moustaid-Moussa N (2019) Mechanisms linking the renin-angiotensin system, obesity, and breast cancer. Endocr Relat Cancer 26:653–672. https://doi.org/10.1530/erc-19-0314
Reinsmoen NL, Lai CH, Heidecke H et al (2010) Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation 90:1473–1477. https://doi.org/10.1097/tp.0b013e3181fd97f1
Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383:45–51. https://doi.org/10.1042/bj20040634
Richard DE, Berra E, Pouyssegur J (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275:26765–26771. https://doi.org/10.1074/jbc.m003325200
Röcken C, Lendeckel U, Dierkes J et al (2005) The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 11:2526–2530. https://doi.org/10.1158/1078-0432.ccr-04-1922
Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H (2007) Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 157(Suppl 2):47–51. https://doi.org/10.1111/j.1365-2133.2007.08273.x
Roth IM, Wickremesekera AC, Wickremesekera SK, Davis PF, Tan ST (2019) Therapeutic targeting of cancer stem cells via modulation of the renin-angiotensin system. Front Oncol 9:745. https://doi.org/10.3389/fonc.2019.00745
Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ (2018) The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev 98:505–553. https://doi.org/10.1152/physrev.00023.2016
Schmieder RE, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K, Regitz-Zagrosek V (2001) Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol 37:175–182. https://doi.org/10.1016/s0735-1097(00)01063-9
Sharma S, Rajan UM, Kumar A, Soni A, Ghosh B (2005) A novel (TG)n(GA)m repeat polymorphism 254 bp downstream of the mast cell chymase (CMA1) gene is associated with atopic asthma and total serum IgE levels. J Hum Genet 50:276–282. https://doi.org/10.1007/s10038-005-0252-x
Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB (2019) Inflammation and cancer. Ann Afr Med 18:121–126. https://doi.org/10.4103/aam.aam_56_18
Smith GR, Missailidis S (2004) Cancer, inflammation and the AT1 and AT2 receptors. J Inflamm 1:3–15. https://doi.org/10.1186/1476-9255-1-3
Soltani-Zangbar MS, Pahlavani B, Zolghadri J, Gharesi-Fard B (2018) Angiotensin type 2 receptor gene polymorphisms and susceptibility to preeclampsia. J Reprod Infertil 19:95–99
Steckelings UM, Paulis L, Namsolleck P, Unger T (2012) AT2 receptor agonists: hypertension and beyond. Curr Opin Nephrol Hypertens 21:142–146. https://doi.org/10.1097/mnh.0b013e328350261b
Telfer NR, Colver GB, Morton CA (2008) Guidelines for the management of basal cell carcinoma. Br J Dermatol 159:35–48. https://doi.org/10.1111/j.1365-2133.2008.08666.x
Teng Y, Yu Y, Li S, Huang Y, Xu D, Tao X, Fan Y (2021) Ultraviolet radiation and basal cell carcinoma: an environmental perspective. Front Public Health 9:666528. https://doi.org/10.3389/fpubh.2021.666528
Tikellis C, Thomas MC (2012) Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012:256294. https://doi.org/10.1155/2012/256294
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238–33243. https://doi.org/10.1074/jbc.m002615200
Uemura H, Ishiguro H, Ishiguro Y, Hoshino K, Takahashi S, Kubota Y (2008) Angiotensin II induces oxidative stress in prostate cancer. Mol Cancer Res 6:250–258. https://doi.org/10.1158/1541-7786.mcr-07-0289
Vairaktaris E, Yapijakis C, Tsigris C et al (2007) Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 46:1097–1102. https://doi.org/10.1080/02841860701373579
Vargas Vargas RA, Varela Millán JM, Fajardo Bonilla E (2022) Renin-angiotensin system: basic and clinical aspects—a general perspective. Endocrinol Diabetes Nutr 69:52–62. https://doi.org/10.1016/j.endien.2022.01.005
Varney VA, Nicholas A, Warner A, Sumar N (2019) IgE-mediated systemic anaphylaxis and its association with gene polymorphisms of ACE angiotensinogen and chymase. J Asthma Allergy 12:343–361. https://doi.org/10.2147/JAA.S213016
Velez JC, Ryan KJ, Harbeson CE et al (2009) Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli. Hypertension 53:790–797. https://doi.org/10.1161/HYPERTENSIONAHA.109.128819
Verdecchia P, Angeli F, Mazzotta G, Martire P, Garofoli M, Gentile G, Reboldi G (2010) Aliskiren versus ramipril in hypertension. Ther Adv Cardiovasc Dis 4:193–200. https://doi.org/10.1177/1753944710369682
Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T (2017) Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 177:359–372. https://doi.org/10.1111/bjd.15321
Warnecke C, Willich T, Holzmeister J, Bottari SP, Fleck E, Regitz-Zagrosek V (1999) Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements. Biochem J 340:17–24
Wegman-Ostrosky T, Soto-Reyes E, Vidal-Millán S, Sánchez-Corona J (2015) The renin-angiotensin system meets the hallmarks of cancer. J Renin Angiotensin Aldosterone Syst 16:227–233. https://doi.org/10.1177/1470320313496858
Wu C, Lu H, Cassis LA, Daugherty A (2011) Molecular and pathophysiological features of angiotensinogen: a mini review. N Am J Med Sci 4:183–190. https://doi.org/10.7156/v4i4p183
Wu Y, Pan X, Jin X (2020) Haplotype-based association study between PRCP gene polymorphisms and essential hypertension in Hani minority group from a remote region of China. J Renin Angiotensin Aldosterone Syst 21:1470320320981316. https://doi.org/10.1177/1470320320981316
Yahiro E, Miura S, Imaizumi S, Uehara Y, Saku K (2013) Chymase inhibitors. Curr Pharm Des 19:3065–3071. https://doi.org/10.2174/1381612811319170014
Yamada T, Horiuchi M, Morishita R, Zhang L, Pratt RE, Dzau VJ (1995) In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J Clin Invest 96:1230–1237. https://doi.org/10.1172/jci118156
Yang M, Zhao J, Xing L, Shi L (2015) The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: a meta-analysis involving 14,122 patients. J Renin Angiotensin Aldosterone Syst 16:1240–1244. https://doi.org/10.1177/1470320314549221
Yapijakis C, Koronellos N, Spyridonidou S et al (2013) Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma. Arch Dermatol Res 305:333–339. https://doi.org/10.1007/s00403-012-1312-7
Yoshiji H, Kuriyama S, Yoshii J et al (2001) Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34:745–750. https://doi.org/10.1053/jhep.2001.28231
Zhang H, Ping XL, Lee PK et al (2001) Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol 158:381–385. https://doi.org/10.1016/s0002-9440(10)63980-6
Zhang Y, Zhang KX, Wang GL, Huang W, Zhu DL (2003) Angiotensin II type 2 receptor gene polymorphisms and essential hypertension. Acta Pharmacol Sin 24:1089–1093
Zhao Y, Xu C (2008) Structure and function of angiotensin converting enzyme and its inhibitors. Chin J Biotech 24:171–176. https://doi.org/10.1016/S1872-2075(08)60007-2
Zou K, Maeda T, Watanabe A et al (2009) Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. J Biol Chem 284:31914–31920. https://doi.org/10.1074/jbc.m109.011437
Funding
This study did not receive any funding.
Author information
Authors and Affiliations
Contributions
IG: design of the work, first draft preparation, critical text corrections and overall editing, figure drawing, approved the final version; MM: first draft preparation, research of the literature, approved the final version; VP: critical text editing, approved the final version; SV: critical text editing, approved the final version; CY: study conception, critical revision of the work, final draft, approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gintoni, I., Mastrogeorgiou, M., Papakosta, V. et al. Genetic Variations Related to Angiotensin II Production and Risk for Basal Cell Carcinoma. Biochem Genet (2024). https://doi.org/10.1007/s10528-024-10746-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10528-024-10746-0